Patent ID: 11944621
Assignee: AUTHENDA PHARMACEUTICALS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 13:
14. The aqueous liquid oral gliptin composition of claim 1, wherein the aqueous liquid oral gliptin composition comprises:
2.5-3.5 w/v % of sitagliptin or a pharmaceutically acceptable salt thereof;
0.1-2.0 w/v % of hydroxyethylcellulose;
0.8-2.0 w/v % of sucralose;
0.2-1.0 w/v % of acesulfame-K;
0.01-0.10 w/v % of butylated hydroxyanisole;
0.1-1.0 w/v % of trisodium citrate dihydrate;
0.1-0.5 w/v % of methyl paraben or a salt thereof;
0.01-0.1 w/v % of disodium edentate;
0.05-0.25 w/v % of polysorbate 80;
0.02-0.15 w/v % of citric acid;
optionally a flavouring agent, a colouring agent, or a combination thereof;
and wherein the pH of the aqueous liquid oral gliptin composition is from 4 to 7.